163 related articles for article (PubMed ID: 27746844)
1. Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review.
Nguyen A; Bhavsar S; Riley E; Caponetti G; Agrawal D
Int Arch Otorhinolaryngol; 2016 Oct; 20(4):382-389. PubMed ID: 27746844
[No Abstract] [Full Text] [Related]
2. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
Susa Y; Masuda Y; Imaizumi H; Namiki A
Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
[TBL] [Abstract][Full Text] [Related]
3. Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review.
Nguyen AH; Bhavsar SB; Riley EM; Caponetti GC; Agrawal DK
Contemp Oncol (Pozn); 2016; 20(6):425-429. PubMed ID: 28239277
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.
Marsh AM; Nguyen AH; Parker TM; Agrawal DK
Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162
[TBL] [Abstract][Full Text] [Related]
6. Associations of high-mobility group box 1 and receptor for advanced glycation end products with acute lung injury in patient with acute aortic dissection.
Zeng Z; Zhang K; Cai J; Wu H; Yue J
Rev Assoc Med Bras (1992); 2021 Sep; 67(9):1251-1255. PubMed ID: 34816916
[TBL] [Abstract][Full Text] [Related]
7. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.
van Zoelen MA; Achouiti A; Schmidt AM; Yang H; Florquin S; Tracey KJ; van der Poll T
Crit Care Med; 2010 Jun; 38(6):1414-22. PubMed ID: 20386310
[TBL] [Abstract][Full Text] [Related]
8. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
9. Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end-products and toll-like receptor-4 in the immunopathology of oral lichen planus: a potential drug target?
Salem A; Almahmoudi R; Vehviläinen M; Salo T
Eur J Oral Sci; 2018 Jun; 126(3):244-248. PubMed ID: 29676511
[TBL] [Abstract][Full Text] [Related]
10. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
12. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
14. From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis.
Mardente S; Mari E; Massimi I; Tafani M; Guerriero R; Morsilli O; Pulcinelli FM; Bianchi ME; Zicari A
Front Immunol; 2017; 8():1946. PubMed ID: 29375570
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid high mobility group box 1 is associated with neuronal death in subarachnoid hemorrhage.
Wang KC; Tang SC; Lee JE; Li YI; Huang YS; Yang WS; Jeng JS; Arumugam TV; Tu YK
J Cereb Blood Flow Metab; 2017 Feb; 37(2):435-443. PubMed ID: 26823474
[TBL] [Abstract][Full Text] [Related]
16. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
17. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
[TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
[TBL] [Abstract][Full Text] [Related]
20. Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma.
Kobayashi S; Kubo H; Suzuki T; Ishizawa K; Yamada M; He M; Yamamoto Y; Yamamoto H; Sasano H; Sasaki H; Suzuki S
Am J Respir Crit Care Med; 2007 Jan; 175(2):184-9. PubMed ID: 17023736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
